Friday, January 12, 2018

FDA Advisers Slam Lipocine's Testosterone Pill, Raising Doubts

FDA Advisers Slam Lipocine's Testosterone Pill, Raising Doubts ...

Forbes-Jan 11, 2018
The questions raised during the advisory panel meeting on Wednesday hint at a broader trend, however—one that calls into question the future of testosterone drugs meant to treat “low T,” a disorder that was popularlized over a decade ago, when TV ads for hormone gels like AbbVie's AndroGel flooded the airwaves.
Post a Comment